Mice that received UBCS039 presented significantly greater expression of the Sirt6, NF-kB, PD-1 and PD-L1 mRNAs in tumor tissue than did mice that received either DMSO or PBS pretreatment (Fig. 5). The gene discussed is SIRT6; the disease is neoplasm.